- Category Marryalyan
- DATE 22 Feb 2023
Cancer Symptom Trials
February 2023
PaCCSC & CST Annual Research Forum 2023
The PaCCSC & CST Annual Research Forum is our principal annual event. Past forums have supported new study ideas, provided networking opportunities, and forged new collaborations. This year’s theme is Bridging Silos: cross-disciplinary clinical trials
We are focused on developing collaborative cross-disciplinary clinical trials to ensure better quality-of-life outcomes for people living with cancer and life-limiting illnesses.
Join us for the PaCCSC & CST Annual Research Forum in Sydney on 15 and 16 March 2023 to be part of the conversation. Find out more and register: uts.edu.au/paccsc-cst-forum-2023
We are pleased to announce our keynote speakers, Professor Maria Fallon, leader of the Edinburgh Palliative and Supportive Care Group at the University of Edinburgh, and Dr Camilla Zimmermann, Head of the Department of Supportive Care at the Princess Margaret Cancer Centre in Toronto.
Culturally and linguistically diverse (CALD) communities
We are undertaking a program of work to investigate the underrepresentation of culturally and linguistically diverse (CALD) communities in cancer clinical research in Australia.
We want to understand why people with cancer from culturally and linguistically diverse (CALD) communities do and don’t participate in cancer clinical research and whether they are given the opportunity to do so. These insights will help inform the design and implementation of inclusive and culturally appropriate cancer clinical trials.
The first project in this program of work is investigating healthcare professionals’ perspectives on the barriers and enablers of cancer clinical trial participation in the Australian Arabic-speaking community.
Find out more at uts.edu.au/cst/cald
IMPACCT Rapid Program
The IMPACCT Rapid Program is a collaborative international quality improvement program that studies the prospective use of medications and non-pharmacological interventions commonly used in palliative care and cancer symptom management.
Cancer-focused series
- Compression and related physical therapies for lymphoedema - series 25
- Diuretics for cancer-related lymphoedema - series 26
- Dressings for malignant cutaneous wounds - series 38
- Ketamine for cancer-related mucositis pain (paediatric) - series 42
If you are administering or using any of these medications or interventions, you can collect data for these series. To find out more and get involved, go to uts.edu.au/rapid.
Cancer symptom management priority setting - children and young adults
We are conducting a number of surveys to identify the most troubling symptoms or side effects of cancer and its treatments for children and young adults.
We are seeking participants who are:
- Health professionals
- Parents or caregivers
- Young adults living with, or after cancer, between 18 and 24 years of age (inclusive) OR adults who had a cancer diagnosis at or before the age of 24
- Adolescents living with or after cancer, between 11 and 17 years old (inclusive)
- Children living with or after cancer, under 10 years old
We will use the survey results to inform research and clinical trials that investigate ways to improve quality of life for children and young adults living with cancer. This is the first survey of its kind in Australia and New Zealand.
Find out more: uts.edu.au/research/impacct/cancer-symptom-trials/cst-projects
Consumer engagement
Our vision is to see every patient receiving the best care regardless of life circumstances, state of health or place of residence. We will only realise our vision with the invaluable contribution of a diverse and engaged Consumer Advisory Group (CAG) with lived experiences as patients or caregivers.
The IMPACCT Consumer Advisory Group (CAG) has been established to ensure that consumers are actively involved in shaping our research, supporting curricula development and providing general guidance on our strategic direction.
If you, or someone you know, has experience as a patient or caregiver in palliative care, aged care, chronic case or cancer supportive care, we’d love you to consider joining the CAG.
Find out how to become a consumer advisor: www.uts.edu.au/impacct/consumers.
CST clinical trials
Our clinical trials contribute to the knowledge base to inform best practice and ensure improved quality of life for people diagnosed with cancer. We investigate accessible, affordable, and appropriate medicines and therapies for people with cancer, including those living at home.
Go to the CST website to find out more about our clinical trials: www.uts.edu.au/cst
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 14 days ago
RT by @cosaoncology: Final days to register for the upcoming COGNO Annual Scientific Meeting! Sunday 13 Oct – Tuesday 15 Oct. Register here bit.ly/4ehF01y #COGNO24 @COSAoncology
Read More >COSAoncology 14 days ago
We are pleased that Bloomhill Cancer Care have renewed their Associated membership. COSA look forward to our ongoing collaboration to improve cancer care and control. Bloomhill members can join COSA at a discounted rate. Join or renew here: bit.ly/3s5mOC6
Read More >COSAoncology 20 days ago
Congrats @RebeccaVenchers @COSA_Surviv Fellow and your co-authors on the publication of your survivorship research @bogda_koczwara @hagsie @M_Jefford
Read More >COSAoncology 20 days ago
Congrats @mijancoubd @COSA_Surviv Fellow and your co-authors on the publication of this important work @rayychan @bogda_koczwara @dr_elysia @garvey_gail
Read More >COSAoncology 27 days ago
RT by @cosaoncology: Register for COGNO ASM, Oct 14-15, Melbourne. Precision Targets: Personalised Care in Neuro-Oncology feat @herveyjumpe & Prof Dunbar. Keynotes & collab opportunities for clinicians, researchers & allied health. Improve patient outcomes together! #COGNO24 bit.ly/4ehF01y
Read More >COSAoncology one month ago
RT by @cosaoncology: REMINDER: The Inspirational Research Grant closes 30 Sept. That gives you 2 weeks to get your application in! If you're on the fence about applying, here are the recipients of the 2024 grants and their projects Read More: buff.ly/3B3fZIQ Apply: buff.ly/4dS0amR
Read More >COSAoncology one month ago
Earlybird registration for the 2024 COSA ASM closes tomorrow! Join or renew as a COSA member now and you'll get a further discount valued at more than the cost of your COSA membership: bit.ly/3hXsDLm
Read More >COSAoncology one month ago
RT by @cosaoncology: Our Supportive Care 2030 Movement Ambition Statements are now published in the @TheLancet's @eClinicalMed. @CancerCareMASCC as the pre-eminent leader in #supponc will work with our partners around the globe to achieve these share ambitions. Full Article tinyurl.com/2b3ksu9e
Read More >COSAoncology one month ago
Earlybird discounts close this Friday for #COSA2024. Review the packed program cosa-2024.p.asnevents.com.au and register today to join us on the Gold Coast in November. #cancer #Oncology
Read More >COSAoncology one month ago
RT by @cosaoncology: Be part of the largest medical radiation event in Australasia! We are thrilled to invite all members of the medical radiation science community to submit abstracts for oral presentations and poster exhibits at ASMIRT/NZIMRT 2025 Conference. 🔗 conference.asmirt.org/nzimrt2025/abs…
Read More >